FDA panel backs KeraVision's corneal ring for myopia
This article was originally published in Clinica
Executive Summary
An FDA advisory panel has unanimously recommended that the agency approves, with certain conditions, KeraVisions' implantable corneal ring for treating myopia. If approved by the FDA, Intacs (formerly called the Corneal Ring) could become the first non-laser treatment for treating people with -1.0 to -3.5 dioptres of myopia in the US.